| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adventures in Slumberland
|
Schotland, Helena M
|
|
|
17 |
12 |
p. 1042
|
artikel
|
| 2 |
Argentina's unanswered stroke health-care question
|
Burton, Adrian
|
|
|
17 |
12 |
p. 1037-1038
|
artikel
|
| 3 |
Bacterial meningitis: more can be done
|
Sejvar, James J
|
|
|
17 |
12 |
p. 1028-1030
|
artikel
|
| 4 |
Bruce Ransom: energy, inspiration, and curiosity
|
Kirby, Tony
|
|
|
17 |
12 |
p. 1039
|
artikel
|
| 5 |
Circadian rhythm and epilepsy
|
Khan, Sofia
|
|
|
17 |
12 |
p. 1098-1108
|
artikel
|
| 6 |
Correction to Lancet Neurol 2018; 17: 895–904
|
|
|
|
17 |
12 |
p. e2-e3
|
artikel
|
| 7 |
Correction to Lancet Neurol 2018; published online Sept 28. http://doi.org/10.1016/S1474-4422(18)30319-3
|
|
|
|
17 |
12 |
p. e1
|
artikel
|
| 8 |
Global burden of motor neuron diseases: mind the gaps
|
Hardiman, Orla
|
|
|
17 |
12 |
p. 1030-1031
|
artikel
|
| 9 |
Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|
|
|
|
17 |
12 |
p. 1061-1082
|
artikel
|
| 10 |
Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|
|
|
|
17 |
12 |
p. 1083-1097
|
artikel
|
| 11 |
IGF-1 for spinal and bulbar muscular atrophy: hope and challenges
|
Hashizume, Atsushi
|
|
|
17 |
12 |
p. 1026-1027
|
artikel
|
| 12 |
LRP10 in α-synucleinopathies
|
Guerreiro, Rita
|
|
|
17 |
12 |
p. 1032-1033
|
artikel
|
| 13 |
LRP10 in α-synucleinopathies
|
Kia, Demis A
|
|
|
17 |
12 |
p. 1032
|
artikel
|
| 14 |
LRP10 in α-synucleinopathies
|
Tesson, Christelle
|
|
|
17 |
12 |
p. 1034
|
artikel
|
| 15 |
LRP10 in α-synucleinopathies
|
Shi, Chang-He
|
|
|
17 |
12 |
p. 1034-1035
|
artikel
|
| 16 |
LRP10 in α-synucleinopathies
|
Pihlstrøm, Lasse
|
|
|
17 |
12 |
p. 1033-1034
|
artikel
|
| 17 |
LRP10 in α-synucleinopathies – Authors' reply
|
Quadri, Marialuisa
|
|
|
17 |
12 |
p. 1035-1036
|
artikel
|
| 18 |
Optimal stroke prevention in patients with patent foramen ovale
|
Meier, Bernhard
|
|
|
17 |
12 |
p. 1027-1028
|
artikel
|
| 19 |
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
|
Kasner, Scott E
|
|
|
17 |
12 |
p. 1053-1060
|
artikel
|
| 20 |
Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial
|
Grunseich, Christopher
|
|
|
17 |
12 |
p. 1043-1052
|
artikel
|
| 21 |
Stroke–heart syndrome: clinical presentation and underlying mechanisms
|
Scheitz, Jan F
|
|
|
17 |
12 |
p. 1109-1120
|
artikel
|
| 22 |
Sylvain Rheims
|
|
|
|
17 |
12 |
p. 1041
|
artikel
|
| 23 |
The role of plasminogen activators in stroke treatment: fibrinolysis and beyond
|
Thiebaut, Audrey M
|
|
|
17 |
12 |
p. 1121-1132
|
artikel
|
| 24 |
Will Europe be ready for the treatment of Alzheimer's disease?
|
The Lancet Neurology,
|
|
|
17 |
12 |
p. 1025
|
artikel
|
| 25 |
William Alexander Hammond
|
Cavanaugh, Ray
|
|
|
17 |
12 |
p. 1040
|
artikel
|
| 26 |
150 years since Charcot's lectures on multiple sclerosis
|
Lubetzki, Catherine
|
|
|
17 |
12 |
p. 1041
|
artikel
|
Tijdschrift beschrijving